Antipsoriatic treatment extends beyond the skin: Recovering of high-density lipoprotein function

Experimental Dermatology

Volumn 23, Issue 10, 2014, Pages 701-704

  Marsche, Gunther ^a   Holzer, Michael ^a   Wolf, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cardiovascular disease; Cholesterol efflux; High density lipoprotein; Inflammation; Proteomics; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG EFFICACY; HEART INFARCTION; HEART PROTECTION; HUMAN; LIPID COMPOSITION; PROTEIN FUNCTION; PROTEOMICS; PSORIASIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; COMPLICATION; METABOLISM; MOUSE; PUVA; RISK FACTOR;

ANIMALS; ANTIBODIES, MONOCLONAL; CARDIOVASCULAR DISEASES; HUMANS; LIPOPROTEINS, HDL; MICE; PROTEOMICS; PSORIASIS; PUVA THERAPY; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907875110     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12483     Document Type: Article

References (49)

1. Yeung H, Takeshita J, Mehta N N et al. JAMA Dermatol 2013: 149: 1173-1179.
2. Gerdes S, Osadtschy S, Buhles N et al. Exp Dermatol 2014: 23: 322-325.
3. Gupta Y, Moller S, Zillikens D et al. Exp Dermatol 2013: 22: 552-553.
4. Tobin A M, Veale D J, Fitzgerald O et al. J Rheumatol 2010: 37: 1386-1394.
5. Gottlieb A B, Dann F. Am J Med 1995b: 122: 1150.e1-1150.e9.
6. Friedewald V E, Cather J C, Gelfand J M et al. Am J Cardiol 2008: 102: 1631-1643.
7. Langan S M, Seminara N M, Shin D B et al. J Invest Dermatol 2012: 132: 556-562.
8. Castro K R, Aikawa N E, Saad C G et al. Clin Dev Immunol 2011: 2011: 352686.
9. Antoniou C, Dessinioti C, Katsambas A et al. Br J Dermatol 2007: 156: 1090-1091.
10. Spanakis E, Sidiropoulos P, Papadakis J et al. J Rheumatol 2006: 33: 2440-2446.
11. Stark G R. J Biol Chem 1964: 239: 1411-1414.
12. Voight B F, Peloso G M, Orho-Melander M et al. Lancet 2012: 380: 572-580.
13. Holzer M, Wolf P, Inzinger M et al. J Invest Dermatol 2014: 134: 635-642.
14. Shah A S, Tan L, Long J L et al. J Lipid Res 2013: 54: 2575-2585.
15. Kontush A, Lhomme M, Chapman M J. J Lipid Res 2013: 54: 2950-2963.
16. Marsche G, Saemann M D, Heinemann A et al. Pharmacol Ther 2013: 137: 341-351.
17. deGoma E M, deGoma R L, Rader D J. J Am Coll Cardiol 2008: 51: 2199-2211.
18. Annema W, von Eckardstein A. Circ J 2013: 77: 2432-2448.
19. Triolo M, Annema W, Dullaart R P et al. Biomark Med 2013: 7: 457-472.
20. Silbernagel G, Schottker B, Appelbaum S et al. Eur Heart J 2013: 34: 3563-3571.
21. Yu Y, Sheth N, Krishnamoorthy P et al. Am J Cardiovasc Dis 2012: 2: 285-292.
22. Mehta N N, Li R, Krishnamoorthy P et al. Atherosclerosis 2012: 224: 218-221.
23. Vaisar T, Pennathur S, Green P S et al. J Clin Invest 2007: 117: 746-756.
24. Holzer M, Trieb M, Konya V et al. Biochim Biophys Acta 2013: 1831: 1442-1448.
25. Holzer M, Wolf P, Curcic S et al. J Lipid Res 2012: 53: 1618-1624.
26. Weichhart T, Kopecky C, Kubicek M et al. J Am Soc Nephrol 2012: 23: 934-947.
27. Alwaili K, Bailey D, Awan Z et al. Biochim Biophys Acta 2011: 1821: 405-415.
28. Riwanto M, Rohrer L, Roschitzki B et al. Circulation 2013: 127: 891-904.
29. Holzer M, Birner-Gruenberger R, Stojakovic T et al. J Am Soc Nephrol 2011: 22: 1331-1341.
30. Watanabe J, Charles-Schoeman C, Miao Y et al. Arthritis Rheum 2012: 64: 1828-1837.
31. Gordon S M, Davidson W S, Urbina E M et al. Diabetes 2013: 62: 2958-2967.
32. Feingold K R, Grunfeld C. J Lipid Res 2012: 53: 1427-1429.
33. Rader D J, Alexander E T, Weibel G L et al. J Lipid Res 2009: 50(Suppl): S189-S194.
34. Toth P P, Barter P J, Rosenson R S et al. J Clin Lipidol 2013: 7: 484-525.
35. Khera A V, Cuchel M, de la Llera-Moya M et al. N Engl J Med 2011: 364: 127-135.
36. Charles-Schoeman C, Lee Y Y, Grijalva V et al. Ann Rheum Dis 2012: 71: 1157-1162.
37. Dowlatshahi E A, van der Voort E A, Arends L R et al. Br J Dermatol 2013: 169: 266-282.
38. Singh T P, Huettner B, Koefeler H et al. Am J Pathol 2011: 178: 699-708.
39. Izaki S, Yamamoto T, Goto Y et al. Br J Dermatol 1996: 134: 1060-1064.
40. Rosenson R S, Hurt-Camejo E. Eur Heart J 2012: 33: 2899-2909.
41. Bhattacharyya T, Nicholls S J, Topol E J et al. JAMA 2008: 299: 1265-1276.
42. Wu J J, Poon K Y, Channual J C et al. Arch Dermatol 2012: 148: 1244-1250.
43. Churton S, Brown L, Shin T M et al. Drugs 2014: 74: 169-182.
44. Jokai H, Szakonyi J, Kontar O et al. J Am Acad Dermatol 2013: 69: 523-529.
45. Ryan C, Leonardi C L, Krueger J G et al. JAMA 2011: 306: 864-871.
46. Tzellos T, Kyrgidis A, Zouboulis C C. J Eur Acad Dermatol Venereol 2013: 27: 622-627.
47. Inzinger M, Weger W, Salmhofer W et al. Acta Derm Venereol 2012: 92: 357-358.
48. Davidson W S, Rodrigueza W V, Lund-Katz S et al. J Biol Chem 1995a: 270: 17106-17113.
49. Davidson W S, Gillotte K L, Lund-Katz S et al. J Biol Chem 1995: 270: 5882-5890.